Here are three things to know:
1. The company plans to repurchase $25 million of its outstanding common stock.
2. Anika Therapeutics will enter into the accelerated stock repurchase agreement with Morgan Stanley & Co. pursuant to a Fixed Dollar Accelerated Share Repurchase Transaction.
3. The company expects the program will begin in late February, and it will be completed in the third quarter of 2016.
More articles on devices:
Globus Medical 2015 net income hits $112.8M: 6 things to know
Neurosurgery device developer addresses market demand for new brain technologies: 6 notes
CoNextions Medical to introduce tendon repair device at AAOS meeting: 3 quick notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
